Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)
China flag China · Delayed Price · Currency is CNY
46.58
-6.42 (-12.11%)
Nov 13, 2026, 3:00 PM CST

SHA:688799 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
113.95238.28164.32211.32182.8160.76
Depreciation & Amortization
70.7571.0569.3161.0248.7934.22
Other Amortization
6.075.782.811.30.530.06
Loss (Gain) From Sale of Assets
00--0-0.18
Asset Writedown & Restructuring Costs
0.030.030.030.480.890.21
Loss (Gain) From Sale of Investments
-84.46-84.4624.16-3.58-7.98-1.71
Provision & Write-off of Bad Debts
1.691.690.311.472.231.31
Other Operating Activities
195.05-0.53-30.16-19.19-5.343.08
Change in Accounts Receivable
-56.44-56.44-118.65-51.3311.32-31.56
Change in Inventory
11.0711.07-55.23-31-43.25-115.58
Change in Accounts Payable
60.4160.41106.3950.84-34.7766.49
Change in Other Net Operating Assets
51.9651.96----
Operating Cash Flow
371.45300.2142.23214.44155.65114.72
Operating Cash Flow Growth
29.48%111.07%-33.68%37.78%35.67%9.62%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-576.61-520.32-233.87-105.76-131.85-92.1
Sale of Property, Plant & Equipment
0.090.070.020.050.120.13
Cash Acquisitions
----0.07-
Divestitures
15.565.97----
Investment in Securities
-303.65-106.47-125.21134.47-111.7-429.6
Other Investing Activities
17.0711.570.2410.3712.744.26
Investing Cash Flow
-847.53-609.17-358.8239.12-230.62-517.3

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-384100.6117.11--
Total Debt Issued
966.57384100.6117.11--
Total Debt Repaid
-460.85-----
Net Debt Issued (Repaid)
505.72384100.6117.11--
Issuance of Common Stock
43.7714.97---674.02
Common Dividends Paid
-40.69-62.96-86.35-84.44-65.66-
Other Financing Activities
-14.97--9.87-10.71-18.36
Financing Cash Flow
493.83336.0114.26-57.47-76.37655.65

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-2.58-0.990.420.010.53-0.03
Net Cash Flow
15.1726.04-201.91196.11-150.82253.04

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-205.16-220.12-91.65108.6823.822.63
Free Cash Flow Growth
---356.70%5.18%-55.56%
Free Cash Flow Margin
-14.81%-14.63%-6.49%7.58%1.84%1.97%
Free Cash Flow Per Share
-1.50-1.64-0.700.830.180.20
Levered Free Cash Flow
222.67-437.09-166.469.89-40.72-33.38
Unlevered Free Cash Flow
227.51-436.69-166.3969.89-40.72-33.38

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
131.13142.82198.54192.83152.18132.83
Change in Working Capital
68.3668.36-88.55-38.36-66.28-83.39